| Biju Babu, MD | |
|
34 S Railroad St, Tamaqua, PA 18252-1927 | |
| (570) 645-1950 | |
| Not Available |
| Full Name | Biju Babu |
|---|---|
| Gender | Male |
| Speciality | Family Medicine |
| Location | 34 S Railroad St, Tamaqua, Pennsylvania |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1437894144 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | MT225076 (Pennsylvania) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Biju Babu, MD 34 S Railroad St, Tamaqua, PA 18252-1927 Ph: () - | Biju Babu, MD 34 S Railroad St, Tamaqua, PA 18252-1927 Ph: (570) 645-1950 |
News Archive
Three inspiring leaders in health education will be honored by The California Wellness Foundation as the 2013 Champions of Health Professions Diversity for their successful efforts to improve the health and wellness of California's most underserved communities.
Stress, to put it bluntly, is bad for you. It can kill you, in fact. A study now reveals that stress causes deterioration in everything from your gums to your heart and can make you more susceptible to everything from the common cold to cancer.
Nintedanib plus docetaxel offers significant efficacy in patients with non-small-cell lung cancer who experience disease progression after first-line chemotherapy, phase III study results show.
The fixed combination of the two drugs insulin degludec and liraglutide (trade name: Xultophy) has been approved since June 2015 also in adults with type 2 diabetes mellitus when oral antidiabetics (OADs) combined with a GLP-1 receptor agonist do not provide adequate glycaemic control. The German Institute for Quality and Efficiency in Health Care (IQWiG) examined in a dossier assessment whether this fixed combination offers an added benefit over the appropriate comparator therapy (ACT).
Janssen Pharmaceuticals, Inc. announced today that the company has entered into a definitive collaboration and license agreement with Bavarian Nordic to leverage their MVA-BN technology, jointly with Janssen's own AdVac® technology, in the development and commercialization of a heterologous prime-boost vaccine for the treatment of Human Papillomavirus (HPV) chronic infections which can lead to cancer.
› Verified 7 days ago
Dr. Thomas J Dirnberger, DO Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 30 Short St, Tamaqua, PA 18252 Phone: 570-386-1288 Fax: 570-386-4724 | |
Bridget Marie Smith, DO Family Medicine Medicare: Medicare Enrolled Practice Location: 34 S Railroad St, Tamaqua, PA 18252 Phone: 570-645-1950 | |
Steven Picozzo, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 34 S. Railroad Street, Tamaqua, PA 18252 Phone: 570-645-1950 | |
Dr. Catherine Wang, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 34 S Railroad St, Tamaqua, PA 18252 Phone: 570-645-1950 Fax: 570-645-1955 | |
Dr. Gayathri Gurumurthy, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 34 S Railroad St, Tamaqua, PA 18252 Phone: 570-645-1950 Fax: 570-645-1955 | |
Benjamin Peter Wenger, DO Family Medicine Medicare: Medicare Enrolled Practice Location: 34 S Railroad St, Tamaqua, PA 18252 Phone: 570-645-1950 Fax: 570-645-1955 |